The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with <i>EGFR</i> Mutations

Παρόμοια τεκμήρια

• The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non–Small Cell Lung Cancer with EGFR Mutations
  από: Heon, Stephanie, κ.ά.
  Έκδοση: (2012)
• Development of Central Nervous System Metastases in Patients with Advanced Non–Small Cell Lung Cancer and Somatic <i>EGFR</i> Mutations Treated with Gefitinib or Erlotinib
  από: Stéphanie Héon, κ.ά.
  Έκδοση: (2010)
• Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib
  από: Heon, Stephanie, κ.ά.
  Έκδοση: (2010)
• Effects of Erlotinib in <i>EGFR</i> Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib
  από: Daniel B. Costa, κ.ά.
  Έκδοση: (2008)
• Noninvasive Detection of <i>EGFR</i> T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer
  από: Yanan Kuang, κ.ά.
  Έκδοση: (2009)